Effect of interferonβ and the development of neutralising antibodies, on reactivation of latent EBV, in patients with multiple sclerosis

被引：0
|
作者：
Farrell, Rachel [1 ]
Antony, Dinu [2 ]
Clark, Duncan [3 ]
Garson, Jeremy [4 ]
Miller, David H. [1 ]
Giovannoni, Gavin [2 ]
机构：
[1] Inst Neurol, London WC1N 3BG, England
[2] QMUL, Inst Cell & Mol Sci, London, England
[3] Barts & London NHS Trust, Dept Virol, London, England
[4] UCLH, Dept Virol, London, England
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [31] Correlation between anti-interferon-beta binding and neutralising antibodies in multiple sclerosis patients on interferon-beta therapy
    Jensen, P. E. H.
    Sellebjerg, F.
    Sondergaard, H. B.
    Sorensen, P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S120 - S120
  • [32] Neutralising antibodies to interferon-beta therapy in relapsing multiple sclerosis: a pilot study
    Lau, A. Y. L.
    Chan, E.
    Lau, K. K.
    Mok, V
    Siu, D. Y. W.
    Lee, R.
    HONG KONG MEDICAL JOURNAL, 2019, 25 (04) : 22 - 25
  • [33] Neutralising antibodies to beta-interferon increase the treatment failure rate in multiple sclerosis
    O'Rourke, K
    Hutchinson, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (04): : 615 - 615
  • [34] Multiple sclerosis patients lacking antibodies in cerebrospinal fluid are less likely to develop neutralising antibodies against interferon-beta
    Lundqvist, M.
    Greiner, E.
    Imrell, K.
    Hillert, J.
    Fogdell-Hahn, A.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S19 - S20
  • [35] Pharmacodynamics of interferon-β in relapsing-remitting multiple sclerosis with and without neutralising antibodies
    Scagnolari, G
    Duda, P
    Alberelli, A
    Lavolpe, V
    Bagnato, F
    Girardi, E
    Trojano, M
    Kappos, L
    Antonelli, G
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S255 - S255
  • [36] Immune response to immunotherapy:: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis
    Hemmer, B
    Stüve, O
    Kieseier, B
    Schellekens, H
    Hartung, HP
    LANCET NEUROLOGY, 2005, 4 (07): : 403 - 412
  • [37] Study of binding and neutralising antibodies to interferon-β in two groups of relapsing-remitting multiple sclerosis patients
    Oscar Fernández
    Cristobalina Mayorga
    Gloria Luque
    Miguel Guerrero
    Rocío Guerrero
    Laura Leyva
    Antonio León
    Miguel Blanca
    Journal of Neurology, 2001, 248 : 383 - 388
  • [38] Assessment of anti-beta-interferon neutralising antibodies status and disease severity in a cohort of multiple sclerosis patients
    Ali, E.
    Farrell, R. A.
    Worthington, V.
    Hennessy, M.
    Counihan, T.
    Giovannoni, G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (09): : 1037 - 1037
  • [39] The effect of neutralising antibodies to interferon beta 1a in neopterin production in multiple sclerosis patients followed for 2 years with repeated measurements
    Bagnato, E.
    Meager, A.
    Deisenhammer, E.
    Bramanti, F.
    Amato, M. P.
    Bellantonio, F.
    Carolei, A.
    Lugaresi, A.
    Zorzon, M.
    Fuchs, D.
    Millefiorini, E.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 : S62 - S62
  • [40] Study of binding and neutralising antibodies to interferon-β in two groups of relapsing-remitting multiple sclerosis patients
    Fernández, O
    Mayorga, C
    Luque, G
    Guerrero, M
    Guerrero, R
    Leyva, L
    León, A
    Blanca, M
    JOURNAL OF NEUROLOGY, 2001, 248 (05) : 383 - 388
12345